Curaleaf operates in the United States, is a fully vertical medical cannabis operator, and sells 90 percent of what the company cultivates and produces in its dispensaries. Curaleaf will be operating in 12 states by the end of 2018 and is licensed to open 69 dispensaries nation-wide.
Curaleaf’s largest footprint is in Florida, where it already has a strong delivery presence and 13 dispensaries, with plans to open 22 more stores in the coming months. Lusardi supports the STATES Act because it would open up banking and debt markets to US cannabis companies.
Subscribe to Cannabis Stock Updates here so you never miss an important update.
Get Real-Time Updates from The Daily Marijuana Observer